Hofseth BioCare Grants AecorBio Co-Founder Options Equal to About 9% of Shares
AecorBio appointed Prof. Karl G. Sylvester as co-founder and consulting chief medical officer. He received options for 972,491 AecorBio shares, about 9% of shares currently outstanding.